ONE-SHOT Trial - Ultra-hypofractionated Single-dose SBRT for Prostate Cancer

PHASE1/PHASE2RecruitingINTERVENTIONAL
Enrollment

45

Participants

Timeline

Start Date

September 1, 2017

Primary Completion Date

October 1, 2022

Study Completion Date

October 1, 2030

Conditions
Prostate Cancer
Interventions
RADIATION

Stereotactic body radition (SBRT)

"Ultra-hypofractionated single-fraction SBRT with urethra-sparing with image-guidance and intra-fractional control motion with the Calypso® system.~* 19 Gy in a single fraction to the whole prostate gland ± proximal seminal vesicles~* 17 Gy in a single fraction to the urethra planning-risk volume (PRV)"

Trial Locations (1)

1205

RECRUITING

University Hospital of Geneva, Geneva

All Listed Sponsors
collaborator

Humanitas Hospital, Italy

OTHER

collaborator

University of Zurich

OTHER

collaborator

Kantonsspital Graubünden

OTHER

lead

University Hospital, Geneva

OTHER